Navigation Links
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
Date:3/27/2009

ovides important insights into the potential synergies obtainable when mesenchymal stem cells are potentiated ex vivo by Ad5IGF-1 and suggest that Corgentin may be able to substantially improve stem cell approaches to the treatment of important disease conditions such as a heart attack. Based on the large body of scientific evidence supporting IGF-1's safety, its potentially beneficial effects in promoting tissue repair and regeneration, and its potential for promoting stem cell responses in vivo, we believe that Corgentin may be an important product candidate for the treatment of heart attack and other cardiovascular indications, including approaches based on the use of stem cells," concluded Mr. Reinhard.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including InnerCool's new RapidBlue(TM) System and its CoolBlue(TM) System, please visit www.innercool.com.

Cardium also has two biologic candidates in clinical development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. T
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
2. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
5. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
6. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
7. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
8. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
9. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
10. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
11. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of diseases of ... that its BNC101 IND submission has passed review by ... to initiate a Phase 1 clinical trial in patients ... pancreatic cancer prior to 31 December 2015. ...
(Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ ... Competitors and Opportunities: 2015 - 2020 Analysis and ... Pain is defined as an unpleasant sensory ... tissue damage. At some point, everyone experiences pain. ...
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... una visión holística de l cuidado ... el trayecto   Royal ... el debut europeo de IntelliSpace Cardiovascular , un ... ofrece sofisticadas herramientas para acceder, analizar y compartir imágenes ...
Breaking Medicine Technology:Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... preclinical,data was presented by Nektar Therapeutics (Nasdaq: ... oncolytic candidate, NKTR-102 (PEG-irinotecan), which demonstrated,enhanced anti-tumor ... colorectal,cancer when co-administered with bevacizumab. Presented at ... Meeting 2008 in San Diego,California, the data ...
... Inc.,(Nasdaq: NUVO ) today announced preclinical data ... activity of NU206 (R-spondin1) in,chemotherapy or radiation-induced oral ... session yesterday at the 2008 American Association,for Cancer ... The study, conducted in mouse models of ...
Cached Medicine Technology:Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 2Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 3Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 4Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 5Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models 2Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models 3
(Date:8/31/2015)... Chicago, IL (PRWEB) , ... August 31, 2015 ... ... Gynecologic Cancer Awareness Month 2015 in September by sharing the facts about the ... focused on BRCA1 and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Move over ... products for men and barbershops are scrambling to meet it. , Reports published this ... for hairstyles and haircare. But the data also reflects that men are getting more ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being ... walking app, Walkadoo , by including an in-app step tracker. , Walkadoo is ... person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day ...
(Date:8/31/2015)... ... August 31, 2015 , ... Juvent Sports ( http://www.juvent.com ) ... major sports figures who are finding joint pain relief after using their revolutionary Micro-Impact ... tennis player in the world said, “For the first time in over 20 years ...
(Date:8/31/2015)... ... August 31, 2015 , ... According to book reviewer Angie Santangeloon ... Your Life with Cancer is an excellent resource for everyone since one in ... to be helpful in explaining what cancer is in a easy to understand medically ...
Breaking Medicine News(10 mins):Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2
... per 1,000 males in the 0-6 age group - has ... Foundation//, to tackle the practice of female foeticide. ... by the Foundation in collaboration with the United Nations Population ... statewide campaign to make people aware of the long-term repercussions ...
... Center in New York say they have identified four genes that ... genes work together. ,Turning off all four genes at ... or metastasise - a study in mice showed. ... planning clinical trials of drugs known to target two of the ...
... patients with untreated sleep apnea are more likely to die than ... ,The study followed 164 patients with heart failure for more than ... had double the death rate of those patients who did not ... death rate was 24% in contrast to 12% for the 113 ...
... Fertility declining among men of north India. And thanks to tight ... of Medical Sciences// (AIIMS), New Delhi. ,A ten-year study ... fertility, reports say. ,The sperm count of a normal ... ml as against 60 million per ml around 30 years ago. ...
... Reports by the Centers for Disease Control and Prevention say there ... Americans//, with a body mass index of 40 or more. ... increased by 50 percent from 2000 to 2005(twice as fast as ... an increase by 24 percent of overweight people (BMI of ...
... the use of insect cells appeared safe and produced ... promises to be an alternative to using embryonated eggs ... preliminary study. ,"All currently licensed influenza ... hen's eggs. There are several well-recognized disadvantages to the ...
Cached Medicine News:Health News:Genes That Spread Breast Cancer Fast Identified 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 3Health News:Denim Lovers Beware, Fertility Could Be in Danger, Says a New Study 2Health News:Experimental Flu Vaccine Appears Promising in Early Tests 2
... the Sysmex KX-21N is ideal for ... testing. This 3-part differential hematology ... on the reliable, field proven Sysmex ... completely automatic START-UP function and one ...
... family of pacemakers features several of ... devices in today's worldwide pacing market. ... features and diagnostic information, the system ... Affinity pacemakers platform. , ,It ...
... family of pacemakers features several of ... devices in today's worldwide pacing market. ... features and diagnostic information, the system ... Affinity pacemakers platform. , ,It ...
... The Identity pacemaker family, which includes ... clinicians with the most advanced pacemaker ... Suppression algorithm, the first and only ... suppress atrial fibrillation (AF). The AF ...
Medicine Products: